课题基金 / 基金详情

Role of cytokines in development of endometriosis

Role of cytokines in development of endometriosis
细胞因子在子宫内膜异位症发展中的作用
批准号:
10671540
负责人:
HARADA Tasuku
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

HARADA Tasuku的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have measured peritoneal fluid (PF) levels of matrix metalloproteinase-9 (MMP-9), its inhibitor, tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-10 (IL-10) in patients with endometriosis. Although the concentrations of MMP-9 was below the detectable level, high concentrations of TIMP-1 and IL-10 were present in the PF. The levels of IL-10 in PF was significantly higher in patients with endometriosis than in patients without endometriosis. In order to examine the effects of IL-6 or IL-10 on the gene expression of TIMP-1, endometrial and endometriotic stromal cells were collected from the uterus or from ovarian chocolate cysts. The stimulatory effects of these cytokines have been elucidated.We have conducted the study to investigate the possible role of IL-6, soluble IL-6 receptor in the growth of endometrial and endometriotic cells. We examined the effect of IL-6, soluble IL-6 receptor or combination of both factors on the proliferation of endometrial and endometriot … More ic stromal cells. IL-6 receptor had no effect on the growth of stromal cells in tissue from the proliferative phase. In contrast, the addition of 200 or 400pg/ml of IL-6 induced significant inhibition of cell proliferation. Similarly, the addition of soluble IL-6 receptor caused significant suppression in the growth of endometrial stromal cells in tissue from the secretory phase, but not the proliferative phase. On the other hand, stromal cells of endometriotic tissues were resistant to IL-6, showing no inhibitory response. Although the combination treatment did not affect the proliferation of stromal cells of proliferative phase and of endometriotic tissues, 10gn/ml of soluble IL-6 inhibited proliferation of stromal cells of the secretory phase in the presence of 1ng/ml of soluble IL-6 receptor. The expression of transcripts of IL-6 receptor and gp130 was observed in the endometrial cells from the proliferative and secretory phases and in endometriotic cells. IL-6 may play a central role in regulation of the growth of endometrial cells as a mediator of endocrine action. Endometriotic cells may behave differently from the normal counterpart in terms of the inhibitory regulation exerted by IL-6. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
T. Harada, H. Yoshioka, et al.: "Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis"Am. J. Obstet Gynecol.. 176. 593-597 (1997)
T. Harada、H. Yoshioka 等人:“患有活动性子宫内膜异位症的不孕患者腹膜液中白细胞介素 6 水平升高”Am。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Yoshioka, T.Harada, T.Iwabe, Y.Nagano, F.Taniguchi, M.Tanikawa, N.Terakawa.: "Menstral cycle-specific inhibition in the proliferation of endometrial stromal cells by interleukin-6 and its soluble receptor"Am J Obstete Gynecol. 180. 1088-94 (1999)
H.Yoshioka、T.Harada、T.Iwabe、Y.Nagano、F.Taniguchi、M.Tanikawa、N.Terakawa.:“白细胞介素 6 及其可溶性受体对月经周期特异性抑制子宫内膜基质细胞的增殖
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Iwabe: "Pathogenetic significance of increased levels of interleukin-8 in peritoneal fluid of patients with endometriosis." Fertil Steril. 69・5. 924-930 (1998)
T.Iwabe:“子宫内膜异位症患者腹腔液中白细胞介素 8 水平升高的病理学意义。”Fertil Steril 69·5 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Harada, H.Yoshioka, S.Yoshida, T.Iwabe, Y.Onohara, M.Tanikawa, N.Terakawa.: "Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis"Am J Obstet Gynecol. 176. 593-7 (1997)
T.Harada、H.Yoshioka、S.Yoshida、T.Iwabe、Y.Onohara、M.Tanikawa、N.Terakawa.:“活动性子宫内膜异位症不孕患者腹腔液中白细胞介素 6 水平升高”Am J Obstet Gynecol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Development of a New Selective Estrogen Receptor Modulator for the Treatment of Endometriosis
    • 批准号:
      18K09290
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2018
    • 负责人:
      HARADA Tasuku
    • 依托单位:
    Molecular basis of novel estrogen receptor variants expressed in endometriotic tissues
    • 批准号:
      24659731
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2012
    • 负责人:
      HARADA Tasuku
    • 依托单位:
    The role of apoptosis in growth and survival of endometriotic cells : its implication for treatment of endometrisois
    • 批准号:
      20591915
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      HARADA Tasuku
    • 依托单位:
    Development of anti-cytokine drugs for treatment of endometriosis
    • 批准号:
      13671715
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2001
    • 负责人:
      HARADA Tasuku
    • 依托单位:
    国内基金
    海外基金
    KCTD10对2型免疫反应(Th2)的调控研究
    • 批准号:
      2020JJ4441
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      任凯群
    • 依托单位:
    IL-6受体泛素化调控机制
    • 批准号:
      32070775
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      李姝
    • 依托单位:
    乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
    • 批准号:
      31970735
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      江静
    • 依托单位:
    USP13调控IL-18诱导的NF-κB活化的分子机制研究
    • 批准号:
      31900556
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2019
    • 负责人:
      林恒
    • 依托单位: